BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24305877)

  • 1. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.
    Wang Y; Wen M; Kwon Y; Xu Y; Liu Y; Zhang P; He X; Wang Q; Huang Y; Jen KY; LaBarge MA; You L; Kogan SC; Gray JW; Mao JH; Wei G
    Cancer Res; 2014 Jan; 74(2):520-31. PubMed ID: 24305877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
    Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
    Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
    Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
    Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
    Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
    Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells.
    Wang Y; Liu X; Zheng H; Wang Q; An L; Wei G
    Int J Mol Med; 2017 Oct; 40(4):1114-1124. PubMed ID: 28902348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer.
    Oh JH; Lee JY; Yu S; Cho Y; Hur S; Nam KT; Kim MH
    Sci Rep; 2019 Feb; 9(1):2977. PubMed ID: 30814639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
    PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
    Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAP80 regulates epithelial-mesenchymal transition related with metastasis and malignancy of cancer.
    Park SY; Korm S; Chung HJ; Choi SJ; Jang JJ; Cho S; Lim YT; Kim H; Lee JY
    Cancer Sci; 2016 Mar; 107(3):267-73. PubMed ID: 26748910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.
    Shen X; Hu K; Cheng G; Xu L; Chen Z; Du P; Zhuang Z
    J Cell Biochem; 2019 Aug; 120(8):12247-12258. PubMed ID: 30864186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.